Pseudonajatoxin b
Pseudonajatoxin B[edit]

Pseudonajatoxin B is a toxin derived from the venom of the false cobra (Pseudonaja textilis), a species of elapid snake found in Australia. This toxin is a member of the three-finger toxin family, which is characterized by its unique structural motif that resembles three fingers extending from a central core.
Structure[edit]
Pseudonajatoxin B is a protein composed of a specific sequence of amino acids. The structure of this toxin is stabilized by several disulfide bonds, which are crucial for maintaining its three-dimensional conformation. The three-finger toxin family, to which Pseudonajatoxin B belongs, is known for its compact and stable structure, which allows it to interact effectively with biological membranes and receptors.

Mechanism of Action[edit]
Pseudonajatoxin B exerts its toxic effects primarily by targeting the nervous system. It binds to specific receptors on the surface of neurons, interfering with normal neurotransmission. This can lead to a range of symptoms, including paralysis and respiratory failure, which are characteristic of neurotoxic snake venoms.
The precise mechanism involves the inhibition of acetylcholine binding at the neuromuscular junction, preventing the transmission of nerve impulses to muscles. This action is similar to that of other well-known neurotoxins, such as alpha-bungarotoxin and cobratoxin.
Biological Significance[edit]
The study of Pseudonajatoxin B and other snake venom components is of significant interest in the field of toxicology and pharmacology. Understanding how these toxins interact with biological systems can lead to the development of new therapeutic agents and antivenoms. Additionally, the unique properties of these toxins make them valuable tools in neuroscience research, particularly in the study of ion channels and receptor function.
Potential Applications[edit]
Research into Pseudonajatoxin B has potential applications in the development of novel analgesics and muscle relaxants. By studying the toxin's interaction with acetylcholine receptors, scientists aim to design drugs that can mimic or block its effects, providing new treatments for conditions such as chronic pain and muscle spasticity.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian